Jump to main content
Jump to site search

Issue 30, 2018
Previous Article Next Article

A protein@metal–organic framework nanocomposite for pH-triggered anticancer drug delivery

Author affiliations

Abstract

We have synthesized a core@shell nanocomposite using biocompatible bovine serum albumin (BSA) as the core and a pH-sensitive metal–organic framework (MOF) as the shell. Doxorubicin (DOX)/BSA nanoparticles as cores have been prepared. A zeolitic imidazolate framework-8 (ZIF-8) layer has been coated on the outer surface of the DOX/BSA core. The ZIF layer acts as a capsule for the safe storage of DOX under physiological conditions. An efficient pH-responsive drug delivery system using a BSA/DOX@ZIF, in which the drug is not released in PBS at pH 7.4 but is released at low pH (5.0–6.0), has been constructed. Compared to the pure ZIF, a better biocompatibility has been obtained using the BSA/DOX@ZIF. The BSA/DOX@ZIF shows a much higher efficacy than free DOX against the breast cancer cell line MCF-7. The positive charges on the outer surface of the BSA/DOX@ZIF also improve its cellular uptake.

Graphical abstract: A protein@metal–organic framework nanocomposite for pH-triggered anticancer drug delivery

Back to tab navigation

Supplementary files

Publication details

The article was received on 04 May 2018, accepted on 04 Jul 2018 and first published on 05 Jul 2018


Article type: Paper
DOI: 10.1039/C8DT01789A
Citation: Dalton Trans., 2018,47, 10223-10228
  •   Request permissions

    A protein@metal–organic framework nanocomposite for pH-triggered anticancer drug delivery

    Z. Liang, Z. Yang, H. Yuan, C. Wang, J. Qi, K. Liu, R. Cao and H. Zheng, Dalton Trans., 2018, 47, 10223
    DOI: 10.1039/C8DT01789A

Search articles by author

Spotlight

Advertisements